U.S. pharma giant copyright scrapped two experimental weight loss products past yr—a when-day by day pill, lotiglipron, on account of elevated liver enzymes along with a two times-daily tablet, danuglipron, due to sturdy side effects—but CEO Albert Bourla has mentioned the company is decided to “Engage in and get” during the weight problems